Rapid unleashing of macrophage efferocytic capacity via transcriptional pause release

© 2024. The Author(s), under exclusive licence to Springer Nature Limited..

During development, inflammation or tissue injury, macrophages may successively engulf and process multiple apoptotic corpses via efferocytosis to achieve tissue homeostasis1. How macrophages may rapidly adapt their transcription to achieve continuous corpse uptake is incompletely understood. Transcriptional pause/release is an evolutionarily conserved mechanism, in which RNA polymerase (Pol) II initiates transcription for 20-60 nucleotides, is paused for minutes to hours and is then released to make full-length mRNA2. Here we show that macrophages, within minutes of corpse encounter, use transcriptional pause/release to unleash a rapid transcriptional response. For human and mouse macrophages, the Pol II pause/release was required for continuous efferocytosis in vitro and in vivo. Interestingly, blocking Pol II pause/release did not impede Fc receptor-mediated phagocytosis, yeast uptake or bacterial phagocytosis. Integration of data from three genomic approaches-precision nuclear run-on sequencing, RNA sequencing, and assay for transposase-accessible chromatin using sequencing (ATAC-seq)-on efferocytic macrophages at different time points revealed that Pol II pause/release controls expression of select transcription factors and downstream target genes. Mechanistic studies on transcription factor EGR3, prominently regulated by pause/release, uncovered EGR3-related reprogramming of other macrophage genes involved in cytoskeleton and corpse processing. Using lysosomal probes and a new genetic fluorescent reporter, we identify a role for pause/release in phagosome acidification during efferocytosis. Furthermore, microglia from egr3-deficient zebrafish embryos displayed reduced phagocytosis of apoptotic neurons and fewer maturing phagosomes, supporting defective corpse processing. Collectively, these data indicate that macrophages use Pol II pause/release as a mechanism to rapidly alter their transcriptional programs for efficient processing of the ingested apoptotic corpses and for successive efferocytosis.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:628

Enthalten in:

Nature - 628(2024), 8007 vom: 25. Apr., Seite 408-415

Sprache:

Englisch

Beteiligte Personen:

Tufan, Turan [VerfasserIn]
Comertpay, Gamze [VerfasserIn]
Villani, Ambra [VerfasserIn]
Nelson, Geoffrey M [VerfasserIn]
Terekhova, Marina [VerfasserIn]
Kelley, Shannon [VerfasserIn]
Zakharov, Pavel [VerfasserIn]
Ellison, Rochelle M [VerfasserIn]
Shpynov, Oleg [VerfasserIn]
Raymond, Michael [VerfasserIn]
Sun, Jerry [VerfasserIn]
Chen, Yitan [VerfasserIn]
Bockelmann, Enno [VerfasserIn]
Stremska, Marta [VerfasserIn]
Peterson, Lance W [VerfasserIn]
Boeckaerts, Laura [VerfasserIn]
Goldman, Seth R [VerfasserIn]
Etchegaray, J Iker [VerfasserIn]
Artyomov, Maxim N [VerfasserIn]
Peri, Francesca [VerfasserIn]
Ravichandran, Kodi S [VerfasserIn]

Links:

Volltext

Themen:

144516-98-3
EC 2.7.7.-
EGR3 protein, human
Early Growth Response Protein 3
Egr3 protein, mouse
Journal Article
RNA Polymerase II
Transcription Factors

Anmerkungen:

Date Completed 12.04.2024

Date Revised 24.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41586-024-07172-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369705823